Search for: "Johnson v. Eli Lilly and Co" Results 1 - 20 of 72
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2024, 10:55 am by Evangelina Cantu
Since 2019, the following pharmaceutical manufacturers have posted seven or more notices of correction: Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novo Nordisk, and Purdue Pharmaceuticals. [read post]
10 Feb 2023, 4:44 am by admin
In the third edition’s chapter on statistics, David Kaye and co-author, the late David A. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
One lot of Glucagon Emergency Kits have been recalled by Eli Lilly and Company due to a potentially dangerous loss of potency. [read post]
31 May 2019, 9:47 am by Rebecca Tushnet
Anheuser-Busch Cos., No. 19-cv-218-wmc (W.D. [read post]
14 Aug 2014, 2:23 pm
Eli Lilly & Co., 744 F.2d 213, 216 (1st Cir. 1984), more appropriate. [read post]
18 Jul 2014, 11:55 am
Wyeth, Inc., ___ N.W.2d ___, 2014 WL 3377071 (Iowa July 11, 2014), but Huck isn’t even the last  case on our scorecard any longer – that honor currently belongs to Johnson v. [read post]
26 Jun 2013, 6:43 am
It is therefore insufficient: see Novartis AG v Johnson & Johnson Medical Ltd [2010] EWCA Civ 1039, [2011] ECC 10 at [77]. [read post]